Laurion Capital Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,332
Closed -$1.41M 571
2023
Q2
$1.41M Buy
+4,332
New +$1.24M 0.01% 339
2020
Q2
Sell
-16,600
Closed -$1M 1019
2020
Q1
$1M Buy
16,600
+13,314
+405% +$985K 0.01% 480
2019
Q4
$244K Buy
+3,286
New +$211K ﹤0.01% 792
2019
Q1
Sell
-82,200
Closed -$3.47M 1057
2018
Q4
$3.47M Buy
+82,200
New +$3.49M 0.06% 357
2018
Q3
Sell
-40,000
Closed -$1.43M 1353
2018
Q2
$1.43M Buy
+40,000
New +$1.29M 0.01% 690

Other funds holding INSP

Laurion Capital Management's INSP Position: Q3 2023 in Review

Laurion Capital Management sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 4,332 shares — an estimated $1.41M sold.

Laurion Capital Management first reported a position in INSP in Q2 2018 and held it in 5 quarters. The position peaked at $3.47M in Q4 2018. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • Laurion Capital Management reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Laurion Capital Management sold 4,332 Inspire Medical Systems shares in Q3 2023, an estimated $1.41M.
  • Laurion Capital Management first reported a position in Inspire Medical Systems in Q2 2018 and held it in 5 quarters.
  • Laurion Capital Management's Inspire Medical Systems position peaked at $3.47M in Q4 2018.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on Laurion Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.